QA: Abbott Laboratories in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000001800_2026_Abbott_Laboratories.pdf

Logs

Graph

Absolute values for 0000001800, Abbott Laboratories

  xvar xval
0 AssetsCurrent 25,996,000,000
1 IntangibleAssetsNetIncludingGoodwill 29,561,000,000
2 PropertyPlantAndEquipmentNet 11,816,000,000
3 remainder_Assets 19,340,000,000
4 LiabilitiesCurrent 16,496,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 19,374,413,649
8 SellingGeneralAndAdministrativeExpense 12,517,384,006
9 ResearchAndDevelopmentExpense 2,970,033,267
10 remainder_Expenses 2,712,299,940
11 remainder_Revenues 44,752,407,122
12 remainder_NetIncome 837,619,261
13 remainder_ComprehensiveNetIncome 1,341,011,649
  yvar yval
0 Assets 86,713,000,000
1 Liabilities 16,496,000,000
2 Expenses 37,574,130,862
3 Revenues 44,752,407,122
4 StockholdersEquity 70,217,000,000
5 NetIncome 8,015,895,521
6 ComprehensiveNetIncome 8,686,401,346
7 BaseVar 93,857,084,447
8 EconomicCapitalRatiobeforeLimitedLiability 3.13
9 EconomicCapitalRatio 3.78

Edgar->Model Mapping

Feature Distribution

Change over Time